Critical assessment of statewide hospital pharmaceutical surge capabilities for chemical, biological, radiological, nuclear, and explosive incidents

Edbert Hsu, Julie A. Casani, Al Romanosky, Michael Millin, Christa M. Singleton, John Donohue, Ernest Feroli, Melvin Rubin, Italo Subbarao, Dianne Whyne, Thomas D. Snodgrass, Gabor D Kelen

Research output: Contribution to journalArticle

Abstract

Introduction: In recent years, government and hospital disaster planners have recognized the increasing importance of pharmaceutical preparedness for chemical, biological, radiological, nuclear, and explosive (CBRNE) events, as well as other public health emergencies. The development of pharmaceutical surge capacity for immediate use before support from the (US) Strategic National Stockpile (SNS) becomes available is integral to strengthening the preparedness of local healthcare networks.Methods: The Pharmaceutical Response Project served as an independent, multidisciplinary collaboration to assess statewide hospital pharmaceutical response capabilities. Surveys of hospital pharmacy directors were conducted to determine pharmaceutical response preparedness to CBRNE threats.Results: All 45 acute care hospitals in Maryland were surveyed, and responses were collected from 80% (36/45). Ninety-two percent (33/36) of hospitals had assessed pharmaceutical inventory with respect to biological agents, 92% (33/36) for chemical agents, and 67% (24/36) for radiological agents. However, only 64% (23/36) of hospitals reported an additional dedicated reserve supply for biological events, 67% (24/36) for chemical events, and 50% (18/36) for radiological events. More than 60% of the hospitals expected to receive assistance from the SNS within ≤48 hours.Conclusions: From a pharmaceutical perspective, hospitals generally remain under-prepared for CBRNE threats and many expect SNS support before it realistically would be available. Collectively, limited antibiotics and other supplies are available to offer prophylaxis or treatment, suggesting that hospitals may have insufficient pharmaceutical surge supplies for a large-scale event. Although most state hospitals are improving pharmaceutical surge capabilities, further efforts are needed.

Original languageEnglish (US)
Pages (from-to)214-218
Number of pages5
JournalPrehospital and Disaster Medicine
Volume22
Issue number3
DOIs
StatePublished - 2007

Fingerprint

Strategic Stockpile
Pharmaceutical Preparations
Surge Capacity
State Hospitals
Biological Factors
Disasters
Emergencies
Public Health
Anti-Bacterial Agents
Delivery of Health Care
Equipment and Supplies

Keywords

  • biological
  • chemical
  • explosive
  • hospital
  • nuclear
  • pharmaceutical
  • preparedness
  • radiological

ASJC Scopus subject areas

  • Emergency
  • Emergency Medicine
  • Medicine(all)

Cite this

Critical assessment of statewide hospital pharmaceutical surge capabilities for chemical, biological, radiological, nuclear, and explosive incidents. / Hsu, Edbert; Casani, Julie A.; Romanosky, Al; Millin, Michael; Singleton, Christa M.; Donohue, John; Feroli, Ernest; Rubin, Melvin; Subbarao, Italo; Whyne, Dianne; Snodgrass, Thomas D.; Kelen, Gabor D.

In: Prehospital and Disaster Medicine, Vol. 22, No. 3, 2007, p. 214-218.

Research output: Contribution to journalArticle

Hsu, Edbert ; Casani, Julie A. ; Romanosky, Al ; Millin, Michael ; Singleton, Christa M. ; Donohue, John ; Feroli, Ernest ; Rubin, Melvin ; Subbarao, Italo ; Whyne, Dianne ; Snodgrass, Thomas D. ; Kelen, Gabor D. / Critical assessment of statewide hospital pharmaceutical surge capabilities for chemical, biological, radiological, nuclear, and explosive incidents. In: Prehospital and Disaster Medicine. 2007 ; Vol. 22, No. 3. pp. 214-218.
@article{d3503d82d45f48fcae2858155f299bb6,
title = "Critical assessment of statewide hospital pharmaceutical surge capabilities for chemical, biological, radiological, nuclear, and explosive incidents",
abstract = "Introduction: In recent years, government and hospital disaster planners have recognized the increasing importance of pharmaceutical preparedness for chemical, biological, radiological, nuclear, and explosive (CBRNE) events, as well as other public health emergencies. The development of pharmaceutical surge capacity for immediate use before support from the (US) Strategic National Stockpile (SNS) becomes available is integral to strengthening the preparedness of local healthcare networks.Methods: The Pharmaceutical Response Project served as an independent, multidisciplinary collaboration to assess statewide hospital pharmaceutical response capabilities. Surveys of hospital pharmacy directors were conducted to determine pharmaceutical response preparedness to CBRNE threats.Results: All 45 acute care hospitals in Maryland were surveyed, and responses were collected from 80{\%} (36/45). Ninety-two percent (33/36) of hospitals had assessed pharmaceutical inventory with respect to biological agents, 92{\%} (33/36) for chemical agents, and 67{\%} (24/36) for radiological agents. However, only 64{\%} (23/36) of hospitals reported an additional dedicated reserve supply for biological events, 67{\%} (24/36) for chemical events, and 50{\%} (18/36) for radiological events. More than 60{\%} of the hospitals expected to receive assistance from the SNS within ≤48 hours.Conclusions: From a pharmaceutical perspective, hospitals generally remain under-prepared for CBRNE threats and many expect SNS support before it realistically would be available. Collectively, limited antibiotics and other supplies are available to offer prophylaxis or treatment, suggesting that hospitals may have insufficient pharmaceutical surge supplies for a large-scale event. Although most state hospitals are improving pharmaceutical surge capabilities, further efforts are needed.",
keywords = "biological, chemical, explosive, hospital, nuclear, pharmaceutical, preparedness, radiological",
author = "Edbert Hsu and Casani, {Julie A.} and Al Romanosky and Michael Millin and Singleton, {Christa M.} and John Donohue and Ernest Feroli and Melvin Rubin and Italo Subbarao and Dianne Whyne and Snodgrass, {Thomas D.} and Kelen, {Gabor D}",
year = "2007",
doi = "10.1017/S1049023X00004696",
language = "English (US)",
volume = "22",
pages = "214--218",
journal = "Prehospital and Disaster Medicine",
issn = "1049-023X",
publisher = "World Association for Disaster and Emergency Medicine",
number = "3",

}

TY - JOUR

T1 - Critical assessment of statewide hospital pharmaceutical surge capabilities for chemical, biological, radiological, nuclear, and explosive incidents

AU - Hsu, Edbert

AU - Casani, Julie A.

AU - Romanosky, Al

AU - Millin, Michael

AU - Singleton, Christa M.

AU - Donohue, John

AU - Feroli, Ernest

AU - Rubin, Melvin

AU - Subbarao, Italo

AU - Whyne, Dianne

AU - Snodgrass, Thomas D.

AU - Kelen, Gabor D

PY - 2007

Y1 - 2007

N2 - Introduction: In recent years, government and hospital disaster planners have recognized the increasing importance of pharmaceutical preparedness for chemical, biological, radiological, nuclear, and explosive (CBRNE) events, as well as other public health emergencies. The development of pharmaceutical surge capacity for immediate use before support from the (US) Strategic National Stockpile (SNS) becomes available is integral to strengthening the preparedness of local healthcare networks.Methods: The Pharmaceutical Response Project served as an independent, multidisciplinary collaboration to assess statewide hospital pharmaceutical response capabilities. Surveys of hospital pharmacy directors were conducted to determine pharmaceutical response preparedness to CBRNE threats.Results: All 45 acute care hospitals in Maryland were surveyed, and responses were collected from 80% (36/45). Ninety-two percent (33/36) of hospitals had assessed pharmaceutical inventory with respect to biological agents, 92% (33/36) for chemical agents, and 67% (24/36) for radiological agents. However, only 64% (23/36) of hospitals reported an additional dedicated reserve supply for biological events, 67% (24/36) for chemical events, and 50% (18/36) for radiological events. More than 60% of the hospitals expected to receive assistance from the SNS within ≤48 hours.Conclusions: From a pharmaceutical perspective, hospitals generally remain under-prepared for CBRNE threats and many expect SNS support before it realistically would be available. Collectively, limited antibiotics and other supplies are available to offer prophylaxis or treatment, suggesting that hospitals may have insufficient pharmaceutical surge supplies for a large-scale event. Although most state hospitals are improving pharmaceutical surge capabilities, further efforts are needed.

AB - Introduction: In recent years, government and hospital disaster planners have recognized the increasing importance of pharmaceutical preparedness for chemical, biological, radiological, nuclear, and explosive (CBRNE) events, as well as other public health emergencies. The development of pharmaceutical surge capacity for immediate use before support from the (US) Strategic National Stockpile (SNS) becomes available is integral to strengthening the preparedness of local healthcare networks.Methods: The Pharmaceutical Response Project served as an independent, multidisciplinary collaboration to assess statewide hospital pharmaceutical response capabilities. Surveys of hospital pharmacy directors were conducted to determine pharmaceutical response preparedness to CBRNE threats.Results: All 45 acute care hospitals in Maryland were surveyed, and responses were collected from 80% (36/45). Ninety-two percent (33/36) of hospitals had assessed pharmaceutical inventory with respect to biological agents, 92% (33/36) for chemical agents, and 67% (24/36) for radiological agents. However, only 64% (23/36) of hospitals reported an additional dedicated reserve supply for biological events, 67% (24/36) for chemical events, and 50% (18/36) for radiological events. More than 60% of the hospitals expected to receive assistance from the SNS within ≤48 hours.Conclusions: From a pharmaceutical perspective, hospitals generally remain under-prepared for CBRNE threats and many expect SNS support before it realistically would be available. Collectively, limited antibiotics and other supplies are available to offer prophylaxis or treatment, suggesting that hospitals may have insufficient pharmaceutical surge supplies for a large-scale event. Although most state hospitals are improving pharmaceutical surge capabilities, further efforts are needed.

KW - biological

KW - chemical

KW - explosive

KW - hospital

KW - nuclear

KW - pharmaceutical

KW - preparedness

KW - radiological

UR - http://www.scopus.com/inward/record.url?scp=35748959663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748959663&partnerID=8YFLogxK

U2 - 10.1017/S1049023X00004696

DO - 10.1017/S1049023X00004696

M3 - Article

C2 - 17894215

AN - SCOPUS:35748959663

VL - 22

SP - 214

EP - 218

JO - Prehospital and Disaster Medicine

JF - Prehospital and Disaster Medicine

SN - 1049-023X

IS - 3

ER -